Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

d'Amico International Shipping S.A. AGM Information 2026

Apr 29, 2026

9964_rns_2026-04-29_5dd448f0-1689-4642-87a5-d39966fd59ae.pdf

AGM Information

Open in viewer

Opens in your device viewer

d'Amico International Shipping S.A.

Société anonyme

Registered office: 25 C, Boulevard Royal, L-2449 Luxembourg
R.C.S. Luxembourg: B 124790
(the « Company »)


MINUTES

of the annual general meeting of shareholders held in Luxembourg on 29 April 2026
at the registered office of the Company
(the “Meeting”)


The Meeting was called to order at 11:30 a.m. (CEST) Luxembourg time and chaired by Mr. Paolo d’Amico, residing professionally in Luxembourg, acting as chairman pro tempore (the “Chairman”).

The Chairman appointed as secretary of the Meeting Mrs. Anna Alberti, residing professionally in Luxembourg (the “Secretary”).

The Meeting elected as scrutineer of the Meeting Mrs. Anna Alberti, residing professionally in Luxembourg (the “Scrutineer”).

The board of the Meeting having thus been duly constituted according to the law and the Articles of Association, the Chairman declared and requested the Secretary to record that:

> The Meeting was duly convened on this date, time and location by means of a convening notice to the shareholders, the directors and the independent auditor (“réviseur d’entreprises agréé”) of the Company which was published on the 27th day of March 2026 in the “Tageblatt”, a Luxembourg daily newspaper, on the 28th day of March 2026 in the Italian daily newspaper “Il Giornale” and on the 30th day of March 2026 in the Recueil Electronique des Sociétés et Associations.

> The agenda of the Meeting was the following:

1) Consideration of the management’s reports on the statutory and consolidated annual accounts of the Company and of the reports of the Company’s independent auditor (“réviseur d’entreprises agréé”) on the consolidated annual accounts of the Company, on the statutory annual accounts of the Company


and on the sustainability statement for the financial year ended on 31 December 2025;

2) Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025;

3) Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025;

4) Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025;

5) Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025;

6) Approval of fees payable to the members of the Board of Directors for the financial year 2026;

7) Renewal of the appointment of the independent auditor of the Company ("réviseur d'enterprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company;

8) Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025.

> According to the attendance list, 78,204,827 shares of the Company, with ISIN Code LU 2592315662, out of 124,106,556 shares of the Company were represented at this Meeting, which shares represent 63.01% of the entire issued share capital of the Company.

> The attendance list signed by the representatives of the shareholders and the proxies of the shareholders represented were all signed by the Chairman, the Secretary and the Scrutineer to remain attached to the minutes.

> The 5,016,774 shares held by the Company itself as at the Record Date ("Own Shares") are not entitled to vote at the present Meeting.

> The Meeting was consequently regularly constituted and could validly decide on all the items on the agenda.

> The Chairman noted the attendance of Mr. Tom Loesch, chairman of the Nomination and Remuneration Committee, in accordance with the Shareholder's Internal Regulations.

The Chairman then submitted to the Meeting the following documents which have been deposited and made available to the public at least 30 days before the Meeting at the Company's registered office and website as well as filed with CONSOB and CSSF and disclosed to the public

2


through the e-Market SDIR mechanism and stored both at Borsa Italiana S.p.A. through the e-market STORAGE mechanism and at the Officially Appointed Mechanism (OAM) of the Luxembourg Stock Exchange:

  • the report of the Board of Directors to the Shareholders, including proposals of resolutions relating to the items on the agenda of the Meeting;
  • the management's reports on the statutory annual accounts of the Company and on the consolidated annual accounts of the Company (the latter including the sustainability statement);
  • the reports of the independent auditor (réviseur d'entreprises agréé) on the statutory annual accounts of the Company, on the consolidated annual accounts of the Company and on the sustainability statement as at 31 December 2025; and
  • the statutory and consolidated annual accounts of the Company (including the sustainability statement) at 31 December 2025.

Thereupon the Meeting approved the above statements and confirmed that it is duly constituted.

The Shareholders then thoroughly considered the items on the agenda and adopted, each share entitling the holder thereof to one vote, the following resolutions:

First resolution

After presentation and review of the statutory annual accounts for the financial year ended on 31 December 2025, of the management's report and of the report of the independent auditor ("réviseur d'entreprises agréé") of the Company on such statutory annual accounts, the Meeting RESOLVED to approve the statutory annual accounts of the Company for the financial year ended on 31 December 2025.

Accordingly, this resolution was passed by 77,699,360 votes in favour, 505,467 votes against, 0 abstentions.

Second resolution

After presentation and review of the consolidated annual accounts for the financial year ended on 31 December 2025, of the management's report on such consolidated annual accounts, and including a sustainability statement, and of the reports of the independent auditor (réviseur d'entreprises agréé) of the Company both on such consolidated annual accounts and on the sustainability statement, the Meeting RESOLVED to approve the consolidated annual accounts of the Company for the financial year ended on 31 December 2025.

3


Accordingly, this resolution was passed by 77,699,360 votes in favour, 505,467 votes against, 0 abstentions.

Third resolution

The Meeting RESOLVED to allocate the statutory net profit for the financial year ending on 31 December 2025 amounting to US$ 53,080,873 as follows:

Retained earnings as at 1 January 2025 USD 46,433,731
Results for the financial year 2025 USD 53,080,873
Other movements in retained earnings during 2025 USD (35,033,950)
Retained earnings as at 31 December 2025 USD 64,178,203
Allocation to the legal reserve in 2026 USD -
--- --- ---
Share Premium as at 31 December 2025 USD 326,657,825.00
Amount distributable following allocation to legal reserve USD 390,836,028.00
Interim Dividend resolved on 6 November 2025 and paid on 19 November 2025 USD (15,941,715.00)
Proposed Annual Dividend 2025 USD 32,121,366.21

and - in accordance with the applicable Luxembourg law and the Company's articles of association – to approve the payment of a gross annual dividend of US$ 0.27 (US$ 0.2295 net, after deducting the maximum applicable withholding tax of 15%) per issued and outstanding share corresponding to a total distribution of approximately US$ 32,121,366.21 to be paid out of the retained earnings to the Company's Shareholders (other than to the treasury shares held by the Company which, pursuant to the decision of the board of directors of the Company, shall not carry a dividend right).

Accordingly, this resolution was passed by 78,204,827 votes in favour, 0 votes against, 0 abstentions.

Fourth resolution

The Meeting RESOLVED to grant full discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025.

Accordingly, this resolution was passed by 77,250,811 votes in favour, 447,730 votes against, 506,286 abstentions.

Fifth resolution

img-0.jpeg


The Meeting RESOLVED to set the management fees payable to the members of the Board of Directors for the financial year 2026, at the aggregate fixed gross amount of up to EUR 560,000.00-, it being specified that such amount shall include the compensation to be paid to those directors "vested with particular offices", as well as to authorize and empower the Board of Directors to allocate up to said aggregate gross amount amongst its members, including those "vested with particular offices".

Accordingly, this resolution was passed by 78,204,827 votes in favour, 0 votes against, 0 abstentions.

Sixth resolution

The Meeting RESOLVED to renew the appointment of Moore Audit S.A., Luxembourg as independent auditor of the Company ("réviseur d'enterprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company.

Accordingly, this resolution was passed by 78,204,827 votes in favour, 0 votes against, 0 abstentions.

Seventh resolution

The Meeting RESOLVED by an advisory vote to approve the 2026 Report on Remuneration comprising the general remuneration policy for the financial year 2026 and the remuneration report for the financial year ended on 31 December 2025.

Accordingly, this resolution was passed by 69,484,861 votes in favour, 8,719,966 votes against, 0 abstentions.

There being no further business, the meeting was adjourned at 12:00 p.m. (CEST).

img-1.jpeg
Chairman

img-2.jpeg
Secretary

img-3.jpeg
Scrutineer


d'Amico International Shipping S.A.
Société anonyme
Registered office: 25 C, Boulevard Royal, L-2449 Luxembourg
RCS Luxembourg: B 124790
(the « Company »)

ATTENDANCE LIST

of the annual general meeting of shareholders of the Company
held in Luxembourg on 29 April 2026

Shareholders Number of Shares Proxyholder Signature
AMERICAN CENTURY ICAV 118 Paolo d'Amico Paolo d'Amico
TEACHER RETIREMENT SYSTEM OF TEXAS 178 Paolo d'Amico Paolo d'Amico
UBS LUX FUND SOLUTIONS 227 Paolo d'Amico Paolo d'Amico
TEACHER RETIREMENT SYSTEM OF TEXAS 282 Paolo d'Amico Paolo d'Amico
AQR FLEX 1 SERIES LLC - SERIES A15 756 Paolo d'Amico Paolo d'Amico
TEACHER RETIREMENT SYSTEM OF TEXAS 768 Paolo d'Amico Paolo d'Amico
HSBC BANK PLC AS TRUSTEE OF STATE STREET AUT WORLD SMALL CAP INDEX EQUITY 790 Paolo d'Amico Paolo d'Amico
LACERA MASTER OPEB TRUST 819 Paolo d'Amico Laxera Master Opeb Trust
AQR FLEX 1 SERIES LLC - SERIES A6 901 Paolo d'Amico AQR Flex 1 Service Opeb Trust

1


2
| | | | |
| --- | --- | --- | --- |
| AQR FLEX 1 SERIES LLC
- SERIES A13 | 1,179 | Paolo d'Amico | Terzo |
| STATE OF ALASKA
RETIREMENT AND
BENEFITS PLANS | 1,784 | Paolo d'Amico | Terzo |
| SPDR PORTFOLIO
EUROPE ETF | 1,847 | Paolo d'Amico | Terzo |
| SOCIAL PROTECTION
FUND | 2,183 | Paolo d'Amico | Terzo |
| AQR FLEX 1 SERIES LLC
- SERIES A16 | 3,404 | Paolo d'Amico | Terzo |
| CITY OF NEW YORK
GROUP TRUST | 3,757 | Paolo d'Amico | Terzo |
| IAM NATIONAL PENSION
FUND | 4,046 | Paolo d'Amico | Terzo |
| THE BARCLAYS BANK UK
RETIREMENT FUND | 4,082 | Paolo d'Amico | Terzo |
| AMERICAN CENTURY
ETF TRUST - AVANTIS
INTERNATIONAL SMALL
CAP EQUITY ETF | 4,173 | Paolo d'Amico | Terzo |
| CITY OF NEW YORK
GROUP TRUST | 4,383 | Paolo d'Amico | Terzo |
| THE TUOMO O.
VUOLTEENAHO 2025
CHARITABLE
REMAINDER UNITRUST | 5,619 | Paolo d'Amico | Terzo |
| AQR FLEX 1 SERIES LLC
SERIES A10 | 6,064 | Paolo d'Amico | Terzo |
| CITY OF NEW YORK
GROUP TRUST | 7,224 | Paolo d'Amico | Terzo |
| ARROWSTREET
INTERNATIONAL EQUITY
ACWI EX US TRUST
FUND | 7,277 | Paolo d'Amico | Terzo |


3
| GMO FUNDS PLC GMO GLOBAL REAL RETURN (UCITS) FUND | 7,584 | Paolo d'Amico | Twice |
| --- | --- | --- | --- |
| CITY OF NEW YORK GROUP TRUST | 7,676 | Paolo d'Amico | Twice |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 7,721 | Paolo d'Amico | Twice |
| AMERICAN CENTURY ETF TRUST - AVANTIS INTERNATIONAL EQUITY FUND | 7,970 | Paolo d'Amico | Twice |
| DIMENSIONAL FUNDS PLC | 8,302 | Paolo d'Amico | Twice |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 8,609 | Paolo d'Amico | Twice |
| STATE STREET GLOBAL ALL CAP EQUITY EXUS INDEX PORTFOLIO | 9,382 | Paolo d'Amico | Twice |
| DIMENSIONAL FUNDS PLC | 9,443 | Paolo d'Amico | Twice |
| MARYLAND STATE RETIREMENT PENSION SYSTEM | 9,746 | Paolo d'Amico | Twice |
| MERCER QIF COMMON CONTRACTUAL FUND | 10,794 | Paolo d'Amico | Twice |
| CITY OF NEW YORK GROUP TRUST | 11,278 | Paolo d'Amico | Twice |
| MONTANA BOARD OF INVESTMENTS | 11,700 | Paolo d'Amico | Twice |
| CITY OF NEW YORK GROUP TRUST | 12,194 | Paolo d'Amico | Twice |
| ARROWSTREET CAPITAL GLOBAL EQUITY LONG/SHORT FUND LIMITED | 12,288 | Paolo d'Amico | Twice |
| SSGA SPDR ETFS EUROPE II PUBLIC LIMITED COMPANY | 12,522 | Paolo d'Amico | Twice |


4
| CITY OF NEW YORK
GROUP TRUST | 12,568 | Paolo d'Amico | |
| --- | --- | --- | --- |
| AQR FLEX 1 SERIES LLC
- SERIES A9 | 12,611 | Paolo d'Amico | |
| GMO BENCHMARK-FREE FUND | 13,211 | Paolo d'Amico | |
| MERCER QIF FUND PLC | 13,351 | Paolo d'Amico | |
| SSB MSCI EAFE SMALL
CAP INDEX SECURITIES
LENDING COMMON FND | 13,591 | Paolo d'Amico | |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 14,038 | Paolo d'Amico | |
| STATE OF NEW JERSEY
COMMON PENSION FUND D | 14,285 | Paolo d'Amico | |
| EURIZON PIR ITALIA AZIONI | 14,730 | Paolo d'Amico | |
| WASHINGTON STATE INVESTMENT BOARD | 14,804 | Paolo d'Amico | |
| WASHINGTON STATE INVESTMENT BOARD | 14,943 | Paolo d'Amico | |
| CITY OF NEW YORK
GROUP TRUST | 15,028 | Paolo d'Amico | |
| THRIVENT INTERNATIONAL ALLOCATION FUND | 15,138 | Paolo d'Amico | |
| AMERICAN CENTURY ICAV | 15,589 | Paolo d'Amico | |
| CITY OF NEW YORK
GROUP TRUST | 16,068 | Paolo d'Amico | |
| CREDIT SUISSE INDEX FUND (LUX) | 16,306 | Paolo d'Amico | |
| THRIFT SAVINGS PLAN | 16,529 | Paolo d'Amico | |
| OMERS ADMINISTRATION CORPORATION | 20,999 | Paolo d'Amico | |


5
| | | | |
| --- | --- | --- | --- |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 21,054 | Paolo d'Amico | Terre |
| SST GLOB ADV TAX EXEMPT RETIREMENT PLANS | 23,435 | Paolo d'Amico | Terre |
| MARYLAND STATE RETIREMENT PENSION SYSTEM | 23,812 | Paolo d'Amico | Terre |
| POLICE AND FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 24,040 | Paolo d'Amico | Terre |
| GMO IMPLEMENTATION FUND | 24,190 | Paolo d'Amico | Terre |
| SPDR S&P INTERNATIONAL SMALL CAP ETF | 25,575 | Paolo d'Amico | Terre |
| THRIVENT INTERNATIONAL ALLOCATION PORTFOLIO | 25,780 | Paolo d'Amico | Terre |
| EURIZON FUND | 28,208 | Paolo d'Amico | Terre |
| MGI FUNDS PLC | 28,281 | Paolo d'Amico | Terre |
| NORTH ATLANTIC STATES CARPENTERS PENSION FUND | 28,645 | Paolo d'Amico | Terre |
| NORTH ATLANTIC STATES CARPENTERS GUARANTEED ANNUITY FUND | 29,299 | Paolo d'Amico | Terre |
| FIDEURAM PIANO BILANCIATO ITALIA 30 | 30,500 | Paolo d'Amico | Terre |
| AQR INTERNATIONAL SMALL CAP EQUITY FUND LP | 33,511 | Paolo d'Amico | Terre |
| NATWEST ST JAMES'S PLACE BALANCED MANAGED UNIT TRUST | 34,221 | Paolo d'Amico | Terre |
| COLLEGE RETIREMENT EQUITIES FUND | 41,843 | Paolo d'Amico | Terre |


6
| | | | |
| --- | --- | --- | --- |
| EURIZON CAPITAL SGR - PIR ITALIA 30 | 43,674 | Paolo d'Amico | Te |
| ARROWSTREET CAPITAL COPLEY FUNDLIMITED | 44,718 | Paolo d'Amico | Te |
| SSGA SPDR ETFS EUROPE II PUBLICLIMITED COMPANY | 52,844 | Paolo d'Amico | Te |
| EURIZON PROGETTO ITALIA 20 | 61,405 | Paolo d'Amico | Te |
| UBS LUX FUND SOLUTIONS | 64,784 | Paolo d'Amico | Te |
| DIMENSIONAL FUNDS PLC | 68,056 | Paolo d'Amico | Te |
| FIDEURAM PIANO BILANCIATO ITALIA 50 | 76,000 | Paolo d'Amico | Te |
| AMERICAN CENTURY ETF TRUST AVANTIS INT SMALL CAP VALUE FUND | 77,674 | Paolo d'Amico | Te |
| TENNESSEE CONSOLIDATED RETIREMENT SYSTEM | 84,156 | Paolo d'Amico | Te |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 94,875 | Paolo d'Amico | Te |
| EURIZON AZIONI ITALIA | 100,000 | Paolo d'Amico | Te |
| EURIZON PROGETTO ITALIA 70 | 111,531 | Paolo d'Amico | Te |
| IAM NATIONAL PENSION FUND | 111,985 | Paolo d'Amico | Te |
| SCOTIA WEALTH QUANTITATIVE GLOBAL SMALL CAP EQUITY POOL | 112,984 | Paolo d'Amico | Te |
| AMERICAN CENTURY ETF TRUST - AVANTIS INTERNATIONAL EQUITY ETF | 128,970 | Paolo d'Amico | Te |


7
| | | | |
| --- | --- | --- | --- |
| SST GLOB ADV TAX EXEMPT RETIREMENT PLANS | 137,022 | Paolo d'Amico | T |
| EURIZON PROGETTO ITALIA 40 | 190,185 | Paolo d'Amico | T |
| CITY OF NEW YORK GROUP TRUST | 202,900 | Paolo d'Amico | T |
| CITY OF NEW YORK GROUP TRUST | 212,391 | Paolo d'Amico | T |
| EURIZON AZIONI PMI ITALIA | 291,462 | Paolo d'Amico | T |
| FIDEURAM PIANO AZIONI ITALIA | 369,906 | Paolo d'Amico | T |
| AMERICAN CENTURY ETF TRUST - AVANTIS INTERNATIONAL SMALL CAP VALUE | 2,319,340 | Paolo d'Amico | T |
| d'Amico International S.A. | 5,630,035 | Anna Alberti | Anna Alberti |
| d'Amico International S.A. | 63,450,000 | Anna Alberti | Anna Alberti |
| Caceis Bank | 663,810 | Paolo d'Amico | T |
| JP MORGAN SE LUX as agent for EBK-AKTIEN-UNIVERSAL-FONDS | 17,108 | Paolo d'Amico | T |
| JPMCBNA as agent for NEW YORK STATE COMMON RETIREMENT FUND | 38,058 | Paolo d'Amico | T |
| JPMCBNA as agent for SHELL TRUST (BERMUDA) LTD AS TRUSTEE OF THE SHELL OVERSEAS CONTRIBUTORY PENSION FUND | 575 | Paolo d'Amico | T |
| BNPP SA DEUTSCH as agent for CBK GLOBAL SM.ART EQUITY SELECTION | 44,276 | Paolo d'Amico | T |


8
| | | | |
| --- | --- | --- | --- |
| BROWN BROTHERS HARR as agent for CATHOLIC RESPONSIBLE INVESTMENTS INTERNATIONAL SMALL-CAP FUND | 28,649 | Paolo d'Amico | ☑ |
| JPMCBNA as agent for ENTERGY CORPORATION RETIREMENT PLANS MASTER TRUST | 27,067 | Paolo d'Amico | ☑ |
| BROWN BROTHERS HARR as agent for LACM WORLD SMALL CAP EQUITY FUND LP | 15,294 | Paolo d'Amico | ☑ |
| JPMCBNA as agent for BLACKROCK INSTITUTIONAL TRUST COMPANY N.A. (Employee Benefit Plans) | 220,916 | Paolo d'Amico | ☑ |
| JPMCBNA as agent for BLACKROCK MSCI EAFE SMALL CAP EQUITY INDEX FUND B | 4,217 | Paolo d'Amico | ☑ |
| JPMCBNA as agent for ALTRIA CLIENT SERVICES MASTER RETIREMENT TRUST | 104,134 | Paolo d'Amico | ☑ |
| JPMCBNA as agent for PRUDENTIAL LEGACY INSURANCE COMPANY OF NEW JERSEY | 29,915 | Paolo d'Amico | ☑ |
| JP MORGAN SE LUX as agent for ROBERT BOSCH GMBH | 58,052 | Paolo d'Amico | ☑ |
| JP MORGAN SE LUX as agent for UI-FONDS BAV RBI AKTIEN | 6,991 | Paolo d'Amico | ☑ |
| BROWN BROTHERS HARR as agent for ACADIAN ALL COUNTRY WORLD EX-US EX-CHINA SMALL-CAP EQUITY | 30,475 | Paolo d'Amico | ☑ |


9
| JPMCBNA as agent for BLACKROCK INSTITUTIONAL TRUST COMPANY N.A. | 3,605 | Paolo d'Amico | ☑ |
| --- | --- | --- | --- |
| JPMCBNA as agent for THRIFT SAVINGS PLAN | 156,586 | Paolo d'Amico | ☑ |
| JPMCBNA as agent for BLACKROCK INSTITUTIONAL TRUST COMPANY N.A. | 5,863 | Paolo d'Amico | ☑ |
| BNPP LUXEMBOURG as agent for BERENBERG EUROPEAN MICRO CAP | 179,047 | Paolo d'Amico | ☑ |
| BNPP LONDON as agent for SONICSHARES GLOBAL SHIPPING ETF | 76,425 | Paolo d'Amico | ☑ |
| JPMCBNA as agent for BLACKROCK INSTITUTIONAL TRUST COMPANY N.A. | 56,543 | Paolo d'Amico | ☑ |
| JPMCBNA as agent for SHELL TRUST (BERMUDA) LIMITED AS TRUSTEE OF THE SHELL INTERNATIONAL PENSION FUND | 338 | Paolo d'Amico | ☑ |
| BNPP LONDON as agent for WILSHIRE INTL EQUITY FUND (VOYA) | 11,746 | Paolo d'Amico | ☑ |
| BROWN BROTHERS HARR as agent for VANGUARD INVESTMENT SERIES PLC | 27,080 | Paolo d'Amico | ☑ |
| JPMCBNA as agent for CHURCH COMMISSIONERS FOR ENGLAND | 533,744 | Paolo d'Amico | ☑ |
| BROWN BROTHERS HARR as agent for ACADIAN INTERNATIONAL SMALL-CAP EQUITY CIT | 41,398 | Paolo d'Amico | ☑ |


BROWN BROTHERS HARR as agent for SEI INSTITUTIONAL INVESTMENTS TRUST WORLD INTERNATIONAL EQUITY FUND 196,193 Paolo d'Amico
BROWN BROTHERS HARR as agent for ACADIAN ALL COUNTRY WORLD EX-US SMALL-CAP EQUITY 34,975 Paolo d'Amico
THE BANK OF NOVA SCOTIA as agent for CC AND L Q MARKET NEUTRAL FUND II 8 Paolo d'Amico
THE BANK OF NOVA SCOTIA as agent for CC AND L Q GLOBAL EQUITY MARKET NEUTRAL FUND 10 Paolo d'Amico
THE BANK OF NOVA SCOTIA as agent for CC AND L Q MARKET NEUTRAL FUND 14 Paolo d'Amico
JPMCBNA as agent for FIDELITY INDEX WORLD ESG SCREENED FUND 142 Paolo d'Amico
BNPP SIDNEY as agent for ONEPATH GLOBAL SHARES - SMALL CAP (UNHEDGED) INDEX 618 Paolo d'Amico
MERRILL LYNCH INT LTD as agent for MW INV STRAT EUREKA FUND AC 497 Paolo d'Amico
MERRILL LYNCH INT LTD as agent for CITADEL SECURITIES LLC 101 Paolo d'Amico
MERRILL LYNCH INT LTD as agent for MARSHALL WACE INV STRAT EUROPEAN TOPS 2,153 Paolo d'Amico
BOFA SEC I EX ML PRO as agent for CPPIB MAP CAYMAN SPC SEGREGATED 65,691 Paolo d'Amico

10


11
| | | | |
| --- | --- | --- | --- |
| BOFA SEC I EX ML PRO as agent for ARROWSTREET INTL EQUITY ALPHA EXTN INTL TRUST | 41,350 | Paolo d'Amico | Twice |
| HSBC BANK PLC as agent for AMUNDI ETF ICAV - S&P 500 EQUAL WEIGHT ESG | 11,868 | Paolo d'Amico | Twice |
| BANQUE DE LUXEMBOURG as agent for RAM (LUX) SYSTEMATIC FUNDS | 91,205 | Paolo d'Amico | Twice |
| BNP PARIBAS NEW YORK as agent for DES VAL INTL PEEQ CASH NON FLIP | 26,317 | Paolo d'Amico | Twice |
| MERRILL LYNCH INT LTD as agent for MW INV STRAT EUREKA FUND AC | 497 | Paolo d'Amico | Twice |
| BOFA SEC I EX ML PRO as agent for BlueHarbour MAP | 27,112 | Paolo d'Amico | Twice |
| BOFA SEC I EX ML PRO as agent for ARROWSTREET INTL EQUITY ALPHA EXTN INTL TRUST | 41,350 | Paolo d'Amico | Twice |
| MERRILL LYNCH INT LTD as agent for MARSHALL WACE INV STRAT EUROPEAN TOPS | 2,153 | Paolo d'Amico | Twice |
| BNPP SA DEUTSCH as agent for UNIVERSAL-INVESTMENT-GESELLSCHAFT MBH (STBV) | 3,209 | Paolo d'Amico | Twice |
| BROWN BROTHERS HARR as agent for ACADIAN GLOBAL SMALL-CAP EQUITY CIT | 17,001 | Paolo d'Amico | Twice |
| JP MORGAN SE LUX as agent for UNIVERSAL-INVESTMENT- | 2,985 | Paolo d'Amico | Twice |


GESELLSCHAFT MBH (ZEIT.)
LEGAL & GENERAL ASSURANCE (PENSIONS MANAGEMENT) LTD 20,055 Paolo d'Amico Te
City of Philadelphia Board of Pensions and Retirement 2,416 Paolo d'Amico Te
1199 SEIU Health Care Employees Pension Fund 177,109 Paolo d'Amico Te
West Virginia Investment Management 70,045 Paolo d'Amico Te
Total 78,204,827

img-4.jpeg

img-5.jpeg

img-6.jpeg


PROXY

I/We, the undersigned, d'Amico International S.A. (name of shareholder) with registered office at/residing at 25 C, boulevard Royal, L-2449 Luxembourg (the “Principal”), being the holder of 5,630,035 registered shares of

d'Amico International Shipping S.A.

a société anonyme governed by the laws of the Grand Duchy of Luxembourg, registered with the Luxembourg Register of Commerce and Companies under number B 124790 and having its registered office at 25 C, boulevard Royal, L-2449 Luxembourg, Grand Duchy of Luxembourg (the "Company"), hereby constitute and appoint Mr. Luca Cappotto (passport n. YC7346193) or Ms. Anna Alberti (identity card n. CA76114KX) or, in his/her absence, (i) the Chairman¹ of the meeting, or alternatively (ii) any of the following delegated representatives of the Company, Maître Remy Bonneau, lawyer, with professional address in the Grand Duchy of Luxembourg or Maître Eugenie Syx, lawyer, with professional address in the Grand Duchy of Luxembourg, or Maître Lucas Hieronimus, lawyer, with professional address in the Grand Duchy of Luxembourg, any other lawyer at Linklaters LLP, with registered office at Avenue John F. Kennedy 35, L-1855 Luxembourg (each an “Agent”) as the Principal’s true and lawful Agent for the purpose of representing the Principal at the annual general meeting of shareholders of the Company to be held at the registered office of the Company, on 29 April 2026 at 11:30 (CEST) Luxembourg time (the “Meeting”), with the following

AGENDA

1) Consideration of the management’s reports on the statutory and consolidated annual accounts of the Company and of the reports of the Company’s independent auditor (“réviseur d’entreprises agréé”) on the consolidated annual accounts of the Company, on the statutory annual accounts of the Company and on the sustainability statement for the financial year ended on 31 December 2025;

2) Consideration and approval of the Company’s statutory annual accounts for the financial year ended on 31 December 2025;


¹ Please note, for the purposes of assessing possible conflicts of interest, that the Chairman of the meeting may potentially be an employee, a member of the Board of Directors, a shareholder, an adviser or service provider of the Company.

y


3) Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025;

4) Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025;

5) Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025;

6) Approval of fees payable to the members of the Board of Directors for the financial year 2026;

7) Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company;

8) Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025.

The Agent may represent the Principal at the Meeting or any adjourned meeting of the annual general meeting of shareholders convened for the purpose of resolving on the above agenda, waive any convening formalities or publications, vote on the Principal's behalf on any resolutions submitted to said meeting, sign any attendance list, minutes or any other documents and, in general, do whatever seems appropriate or useful, promising ratification.

The Agent is more in particular instructed to vote in the following manner on behalf of the Principal on the resolutions of the agenda of the Meeting:

1) Consideration of the management's reports on the statutory and consolidated annual accounts of the Company and of the reports of the Company's independent auditor ("réviseur d'entreprises agréé") on the consolidated annual accounts of the Company, on the statutory annual accounts of the Company and on the sustainability statement for the financial year ended on 31 December 2025.

N/A

2) Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025.

y


For X

Against ☐

Abstention ☐

3) Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025.

For X

Against ☐

Abstention ☐

4) Approval of the proposal of the Board of Directors to allocate the statutory net profit for the financial year ending on 31 December 2025 amounting to US$ 53,080,873 as follows:

Retained earnings as at 1 January 2025 USD 46,433,731
Results for the financial year 2025 USD 53,080,873
Other movements in retained earnings during 2025 USD (35,033,950)
Retained earnings as at 31 December 2025 USD 64,178,203
Allocation to the legal reserve in 2026 USD -
--- --- ---
Share Premium as at 31 December 2025 USD 326,657,825.00
Amount distributable following allocation to legal reserve USD 390,836,028.00
Interim Dividend resolved on 6 November 2025 and paid on 19 November 2025 USD (15,941,715.00)
Proposed Annual Dividend 2025 USD 32,121,366.21

and - in accordance with the applicable Luxembourg law and the Company's articles of association – to approve the payment of a gross annual dividend of US$ 0.27 (US$ 0.2295 net, after deducting the maximum applicable withholding tax of 15%) per issued and outstanding share corresponding to a total distribution of approximately US$ 32,121,366.21 to be paid out of the retained earnings to the Company's Shareholders (other than to the treasury shares held by the Company which, pursuant to the decision of the board of directors of the Company, shall not carry a dividend right).

For X

Against ☐

Abstention ☐

T

θ


5) Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025.

For ☑ Against ☐ Abstention

6) Approval of management fees payable to the members of the Board of Directors for the financial year 2026.

For ☑ Against ☐ Abstention

7) Approval of the renewal of the appointment of Moore Audit S.A., Luxembourg as independent auditor of the Company ("réviseur d'enterprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company.

For ☑ Against ☐ Abstention

8) Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025.

For ☑ Against ☐ Abstention

Please indicate with an "X" in the appropriate boxes how you wish the Agent to vote.

The Principal acknowledges that the Agent is to vote as instructed in respect of the resolutions specified above and that, if the appropriate boxes are not ticked for each of the above resolutions, the Agent will abstain on the resolutions in respect of which the boxes are not ticked and, unless instructed otherwise, on any other business (including amendments to resolutions) which may come before the Meeting.

1


The Principal acknowledges that if he completes and returns this proxy form this will not prevent Principal from attending in person and voting at the Meeting should the Principal subsequently decide to do so.

This proxy shall be sent by email to ABN AMRO via e-mail to [email protected] no later than 5 p.m. (CEST) Luxembourg time, of the 24th day of April 2026.

As mentioned in the Convening Notice, upon provision of the Certificate of Holding and the Proxy Form, and subject to the Declaration of Intention to Participate being timely received by the Company, the Shareholder will receive Registration Certificate which will serve as an admission ticket for the Proxy Holder to the Meeting.

On the day of the Meeting date, the proxy holder is requested to produce to the Meeting in order to present it to the board of the Meeting: the Registration Certificate, as well as the original of the executed proxy if sent by e-mail, along with a copy of a valid ID document in order to identify the proxy holder.

Executed in Luxembourg on 16.04.2026

By

Name of shareholder: d'Amico International S.A.

Represented by

Name of representative: Enio Spurio

Title of representative: Member of the Board of Directors

T


PROXY

I/We, the undersigned, d'Amico International S.A. (name of shareholder) with registered office at/residing at 25 C, boulevard Royal, L-2449 Luxembourg (the “Principal”), being the holder of 63,450,000 registered shares of

d'Amico International Shipping S.A.

a société anonyme governed by the laws of the Grand Duchy of Luxembourg, registered with the Luxembourg Register of Commerce and Companies under number B 124790 and having its registered office at 25 C, boulevard Royal, L-2449 Luxembourg, Grand Duchy of Luxembourg (the “Company”), hereby constitute and appoint Mr. Luca Cappotto (passport n. YC7346193) or Ms. Anna Alberti (identity card n. CA76114KX) or, in his/her absence, (i) the Chairman¹ of the meeting, or alternatively (ii) any of the following delegated representatives of the Company, Maître Remy Bonneau, lawyer, with professional address in the Grand Duchy of Luxembourg or Maître Eugenie Syx, lawyer, with professional address in the Grand Duchy of Luxembourg, or Maître Lucas Hieronimus, lawyer, with professional address in the Grand Duchy of Luxembourg, any other lawyer at Linklaters LLP, with registered office at Avenue John F. Kennedy 35, L-1855 Luxembourg (each an “Agent”) as the Principal’s true and lawful Agent for the purpose of representing the Principal at the annual general meeting of shareholders of the Company to be held at the registered office of the Company, on 29 April 2026 at 11:30 (CEST) Luxembourg time (the “Meeting”), with the following

AGENDA

1) Consideration of the management’s reports on the statutory and consolidated annual accounts of the Company and of the reports of the Company’s independent auditor (“réviseur d’entreprises agréé”) on the consolidated annual accounts of the Company, on the statutory annual accounts of the Company and on the sustainability statement for the financial year ended on 31 December 2025;

2) Consideration and approval of the Company’s statutory annual accounts for the financial year ended on 31 December 2025;


¹ Please note, for the purposes of assessing possible conflicts of interest, that the Chairman of the meeting may potentially be an employee, a member of the Board of Directors, a shareholder, an adviser or service provider of the Company.


3) Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025;

4) Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025;

5) Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025;

6) Approval of fees payable to the members of the Board of Directors for the financial year 2026;

7) Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company;

8) Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025.

The Agent may represent the Principal at the Meeting or any adjourned meeting of the annual general meeting of shareholders convened for the purpose of resolving on the above agenda, waive any convening formalities or publications, vote on the Principal's behalf on any resolutions submitted to said meeting, sign any attendance list, minutes or any other documents and, in general, do whatever seems appropriate or useful, promising ratification.

The Agent is more in particular instructed to vote in the following manner on behalf of the Principal on the resolutions of the agenda of the Meeting:

1) Consideration of the management's reports on the statutory and consolidated annual accounts of the Company and of the reports of the Company's independent auditor ("réviseur d'entreprises agréé") on the consolidated annual accounts of the Company, on the statutory annual accounts of the Company and on the sustainability statement for the financial year ended on 31 December 2025.

N/A

2) Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025.

1


For X

Against ☐

Abstention ☐

3) Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025.

For X

Against ☐

Abstention ☐

4) Approval of the proposal of the Board of Directors to allocate the statutory net profit for the financial year ending on 31 December 2025 amounting to US$ 53,080,873 as follows:

Retained earnings as at 1 January 2025 USD 46,433,731
Results for the financial year 2025 USD 53,080,873
Other movements in retained earnings during 2025 USD (35,033,950)
Retained earnings as at 31 December 2025 USD 64,178,203
Allocation to the legal reserve in 2026 USD -
--- --- ---
Share Premium as at 31 December 2025 USD 326,657,825.00
Amount distributable following allocation to legal reserve USD 390,836,028.00
Interim Dividend resolved on 6 November 2025 and paid on 19 November 2025 USD (15,941,715.00)
Proposed Annual Dividend 2025 USD 32,121,366.21

and - in accordance with the applicable Luxembourg law and the Company's articles of association – to approve the payment of a gross annual dividend of US$ 0.27 (US$ 0.2295 net, after deducting the maximum applicable withholding tax of 15%) per issued and outstanding share corresponding to a total distribution of approximately US$ 32,121,366.21 to be paid out of the retained earnings to the Company's Shareholders (other than to the treasury shares held by the Company which, pursuant to the decision of the board of directors of the Company, shall not carry a dividend right).

For X

Against ☐

Abstention ☐

4

Q


5) Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025.

For ☑ Against ☐ Abstention

6) Approval of management fees payable to the members of the Board of Directors for the financial year 2026.

For ☑ Against ☐ Abstention

7) Approval of the renewal of the appointment of Moore Audit S.A., Luxembourg as independent auditor of the Company ("réviseur d'enterprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company.

For ☑ Against ☐ Abstention

8) Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025.

For ☑ Against ☐ Abstention

Please indicate with an "X" in the appropriate boxes how you wish the Agent to vote.

The Principal acknowledges that the Agent is to vote as instructed in respect of the resolutions specified above and that, if the appropriate boxes are not ticked for each of the above resolutions, the Agent will abstain on the resolutions in respect of which the boxes are not ticked and, unless instructed otherwise, on any other business (including amendments to resolutions) which may come before the Meeting.


The Principal acknowledges that if he completes and returns this proxy form this will not prevent Principal from attending in person and voting at the Meeting should the Principal subsequently decide to do so.

This proxy shall be sent by email to ABN AMRO via e-mail to [email protected] no later than 5 p.m. (CEST) Luxembourg time, of the 24th day of April 2026.

As mentioned in the Convening Notice, upon provision of the Certificate of Holding and the Proxy Form, and subject to the Declaration of Intention to Participate being timely received by the Company, the Shareholder will receive Registration Certificate which will serve as an admission ticket for the Proxy Holder to the Meeting.

On the day of the Meeting date, the proxy holder is requested to produce to the Meeting in order to present it to the board of the Meeting: the Registration Certificate, as well as the original of the executed proxy if sent by e-mail, along with a copy of a valid ID document in order to identify the proxy holder.

Executed in Luxembourg on 16.04.2026 2026.

By

Name of shareholder: d'Amico International S.A.

Represented by

Name of representative: Enio Spurio

Title of representative: Member of the Board of Directors

1


ABN·AMRO

FACULTY CITY FUNG MODERN MODERN MODERN MODERN MODERN MODERN MODERN MODERN
MULTIPLE MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE
MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE MANUFACTURE
OURSEY PROSTITS (TALA 9) MADAMYONTUNG/TALAB 295050 295050 295050 295050 295050 295050 295050 295050 295050
OURSEY PROSTITS (TALA 7) MADAMYONTUNG/TALAB 212230 212230 212230 212230 212230 212230 212230 212230 212230
THE TURKEY'S EQUIPMENTED EQUIPMENT THULS REMANDED UNTIL 12 COURSELAND 3500 3500 3500 3500 3500 3500 3500 3500 3500
MUB RATE LIBRARY-LEGENCY-40 ZAMARUANVEDHEDMAN 6094 6094 6094 6094 6094 6094 6094 6094 6094
MANUFACTURERS HOTEL SCHOOL EQUIPMENT (MANUFACTURE) MANUFACTURERS HOTEL SCHOOL EQUIPMENT (MANUFACTURE) 11786 11786 11786 11786 11786 11786 11786 11786 11786
DARS INFLUENCE HOTEL (UAS) KITCHERING/ROADING 24286 24286 24286 24286 24286 24286 24286 24286 24286
CULTURAL FUND (KODA) MANUFACTURE 24286 24286 24286 24286 24286 24286 24286 24286 24286
CULTURAL FUND (KOMEN) KOMEN/ROADING 15000 15000 15000 15000 15000 15000 15000 15000 15000
CULTURAL FUND (KUMULATS) KUMULATS/ROADING 15000 15000 15000 15000 15000 15000 15000 15000 15000
CULTURAL FUND (KUMULATS) KUMULATS/ROADING 15000 15000 15000 15000 15000 15000 15000 15000 15000

12


2

DENTE STREET GLOBAL ALL-ENT EQUITY DRUG INDEX PORTROUGH SHREWBAHURGEXEAPAB 9382 9382 9382 9382 9382 9382 9382
LADENHORNSTA SPRA TRUST HIBUZADRUG 814 814 814 814 814 814 814
CITY OF NEW YORK VACUITY TRUST SHREWBAHURGEXEAPAB 11199 11199 11199 11199 11199 11199 11199 11199
CITY OF NEW YORK VACUITY TRUST SHREWBAHURGEXEAPAB 9707 9707 9707 9707 9707 9707 9707 9707
HAWKKERS CENTURY GYM KENNESHURGEXEAPAB 15180 15180 15180 15180 15180 15180 15180
HAWKKERS CENTURY GYM KHOLNAHRA 1181 1181 1181 1181 1181 1181 1181
HARWATERSET INTERNATIONAL EQUITY AGENCY 25 TRUST PLANS SHREWBAHURGEXEAPAB 7277 7277 7277 7277 7277 7277 7277
HARWATERSET INTERNATIONAL EQUITY AGENCY 1000 SHREWBAHURGEXEAPAB 19611 19611 19611 19611 19611 19611 19611
STATE OF ALASKA RETIREMENT AND REPORTS PLANS SHREWBAHURGEXEAPAB 1764 1764 1764 1764 1764 1764 1764
MASHINGTON STATE PENITENTIAN SHREWBAHURGEXEAPAB 14842 14842 14842 14842 14842 14842 14842
MASHINGTON STATE PENITENTIAN SHREWBAHURGEXEAPAB 14804 14804 14804 14804 14804 14804 14804
NEW YORK STATE TRADITION RETIREMENT SYSTEM SHREWBAHURGEXEAPAB 11004 11004 11004 11004 11004 11004 11004
DEC GLOBAL RESERVING TRANSPORT PLANS SHREWBAHURGEXEAPAB 127151 127151 127151 127151 127151 127151 127151
DEKOND RETIREMENT SYSTEM OF TENNIS SHREWBAHURGEXEAPAB 9701 9701 9701 9701 9701 9701 9701
DETRO PORTROUGH PLANTS 2017 SHREWBAHURGEXEAPAB 2847 2847 2847 2847 2847 2847 2847
DEC GLOBAL RESERVING TRANSPORT PLANS SHREWBAHURGEXEAPAB 15615 15615 15615 15615 15615 15615 15615
DEC MISC. SHEET PLANS, CIVIL WATER SECURITIES (LEADING COMMODITIES) SHREWBAHURGEXEAPAB 13595 13595 13595 13595 13595 13595 13595
COLLEGE RETIREMENT EQUITY PLANS SHREWBAHURGEXEAPAB 41843 41843 41843 41843 41843 41843 41843
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SHREWBAHURGEXEAPAB 14158 14158 14158 14158 14158 14158 14158
DETRO MUT RETIREMENT PLANS, CIVIL STO SHREWBAHURGEXEAPAB 23275 23275 23275 23275 23275 23275 23275
NORTH ATLANTIC STATE CAMPING TOWN PLANS SHREWBAHURGEXEAPAB 28645 28645 28645 28645 28645 28645 28645
NORTH ATLANTIC STATE CAMPING TOWN PLANS SHREWBAHURGEXEAPAB 29230 29230 29230 29230 29230 29230 29230
NORTH ATLANTIC STATE CAMPING TOWN PLANS SHREWBAHURGEXEAPAB 14185 14185 14185 14185 14185 14185 14185
CITY OF NEW YORK VACUITY TRUST USLSTG18634 4583 4583 4583 4583 4583 4583 4583
CITY OF NEW YORK VACUITY TRUST USLSTG18634 11279 11279 11279 11279 11279 11279 11279
HIGH SURVEY 1994-2011 SHREWBAHURGEXEAPAB 9604 9604 9604 9604 9604 9604 9604
HIGH SURVEY 1994-2011 SHREWBAHURGEXEAPAB 801 801 801 801 801 801 801

PROXY

I/We, the undersigned, CACEIS BANK (name of shareholder) with registered office at/residing at 91 Rue Gabriel Péri 92120 Montrouge France (the “Principal”), being the holder of 663810 registered shares of

d’Amico International Shipping S.A.

a société anonyme governed by the laws of the Grand Duchy of Luxembourg, registered with the Luxembourg Register of Commerce and Companies under number B 124790 and having its registered office at 25 C, boulevard Royal, L-2449 Luxembourg, Grand Duchy of Luxembourg (the “Company”), hereby constitute and appoint...

...or, in his/her absence, (i) the Chairman¹ of the meeting, or alternatively (ii) any of the following delegated representatives of the Company, Maître Remy Bonneau, lawyer, with professional address in the Grand Duchy of Luxembourg or Maître Eugenie Syx, lawyer, with professional address in the Grand Duchy of Luxembourg, or Maître Lucas Hieronimus, lawyer, with professional address in the Grand Duchy of Luxembourg, any other lawyer at Linklaters LLP, with registered office at Avenue John F. Kennedy 35, L-1855 Luxembourg (each an “Agent”) as the Principal’s true and lawful Agent for the purpose of representing the Principal at the annual general meeting of shareholders of the Company to be held at the registered office of the Company, on 29 April 2026 at 11:30 (CEST) Luxembourg time (the “Meeting”), with the following

AGENDA

1) Consideration of the management’s reports on the statutory and consolidated annual accounts of the Company and of the reports of the Company’s independent auditor (“réviseur d’entreprises agréé”) on the consolidated annual accounts of the Company, on the statutory annual accounts of the Company and on the sustainability statement for the financial year ended on 31 December 2025;

2) Consideration and approval of the Company’s statutory annual accounts for the financial year ended on 31 December 2025;

¹ Please note, for the purposes of assessing possible conflicts of interest, that the Chairman of the meeting may potentially be an employee, a member of the Board of Directors, a shareholder, an adviser or service provider of the Company.

Tf


3) Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025;

4) Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025;

5) Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025;

6) Approval of fees payable to the members of the Board of Directors for the financial year 2026;

7) Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company;

8) Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025.

The Agent may represent the Principal at the Meeting or any adjourned meeting of the annual general meeting of shareholders convened for the purpose of resolving on the above agenda, waive any convening formalities or publications, vote on the Principal's behalf on any resolutions submitted to said meeting, sign any attendance list, minutes or any other documents and, in general, do whatever seems appropriate or useful, promising ratification.

The Agent is more in particular instructed to vote in the following manner on behalf of the Principal on the resolutions of the agenda of the Meeting:

1) Consideration of the management's reports on the statutory and consolidated annual accounts of the Company and of the reports of the Company's independent auditor ("réviseur d'entreprises agréé") on the consolidated annual accounts of the Company, on the statutory annual accounts of the Company and on the sustainability statement for the financial year ended on 31 December 2025.

N/A

2) Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025.

10


For ☑
Against ☐
Abstention ☐

3) Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025.

For ☑
Against ☐
Abstention ☐

4) Approval of the proposal of the Board of Directors to allocate the statutory net profit for the financial year ending on 31 December 2025 amounting to US$ 53,080,873 as follows:

Retained earnings as at 1 January 2025 USD 46,433,731
Results for the financial year 2025 USD 53,080,873
Other movements in retained earnings during 2025 USD (35,033,950)
Retained earnings as at 31 December 2025 USD 64,178,203
Allocation to the legal reserve in 2026 USD -
--- --- ---
Share Premium as at 31 December 2025 USD 326,657,825.00
Amount distributable following allocation to legal reserve USD 390,836,028.00
Interim Dividend resolved on 6 November 2025 and paid on 19 November 2025 USD (15,941,715.00)
Proposed Annual Dividend 2025 USD 32,121,366.21

and - in accordance with the applicable Luxembourg law and the Company's articles of association – to approve the payment of a gross annual dividend of US$ 0.27 (US$ 0.2295 net, after deducting the maximum applicable withholding tax of 15%) per issued and outstanding share corresponding to a total distribution of approximately US$ 32,121,366.21 to be paid out of the retained earnings to the Company's Shareholders (other than to the treasury shares held by the Company which, pursuant to the decision of the board of directors of the Company, shall not carry a dividend right).

For ☑
Against ☐
Abstention ☐

198


5) Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025.

For ☑ Against ☐ Abstention ☐

6) Approval of management fees payable to the members of the Board of Directors for the financial year 2026.

For ☑ Against ☐ Abstention ☐

7) Approval of the renewal of the appointment of Moore Audit S.A., Luxembourg as independent auditor of the Company ("réviseur d'enterprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company.

For ☑ Against ☐ Abstention ☐

8) Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025.

For ☐ Against ☑ Abstention ☐

Please indicate with an "X" in the appropriate boxes how you wish the Agent to vote.

The Principal acknowledges that the Agent is to vote as instructed in respect of the resolutions specified above and that, if the appropriate boxes are not ticked for each of the above resolutions, the Agent will abstain on the resolutions in respect of which the boxes are not ticked and, unless instructed otherwise, on any other business (including amendments to resolutions) which may come before the Meeting.


The Principal acknowledges that if he completes and returns this proxy form this will not prevent Principal from attending in person and voting at the Meeting should the Principal subsequently decide to do so.

This proxy shall be sent by email to ABN AMRO via e-mail to [email protected] no later than 5 p.m. (CEST) Luxembourg time, of the 24th day of April 2026.

As mentioned in the Convening Notice, upon provision of the Certificate of Holding and the Proxy Form, and subject to the Declaration of Intention to Participate being timely received by the Company, the Shareholder will receive Registration Certificate which will serve as an admission ticket for the Proxy Holder to the Meeting.

On the day of the Meeting date, the proxy holder is requested to produce to the Meeting in order to present it to the board of the Meeting: the Registration Certificate, as well as the original of the executed proxy if sent by e-mail, along with a copy of a valid ID document in order to identify the proxy holder.

Executed in London on 14/04/2026.

By Broadridge Financial Solutions Ltd

Name of shareholder: CACEIS BANK

Represented by Broadridge Financial Solutions Ltd

Name of representative: Oscar Mendez

Title of representative: Operations Manager, Global Market Operations

img-0.jpeg

Y


LEGAL AND GENERAL ASSURANCE (PENSIONS MANAGEMENT) LIMITED

MSCI WORLD SMALL CAP ESG EXCLUSIONS FUND 1 COLEMAN STREET LONDON LONDON CITY OF EC2R 5AA GB, GBR

Registration number: 1.1744.00153

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 20055.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 20,055 0 0 20,055
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 20,055 0 0 20,055
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 20,055 0 0 20,055
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 20,055 0 0 20,055
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 20,055 0 0 20,055
7. Renewal of the appointment of the independent auditor of the Company ("récoute; viseur d'entreprises agrégate; écoute;") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 20,055 0 0 20,055
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 20,055 0 20,055

Tf 0


WEST VIRGINIA INVESTMENT MANAGEMENT BOARD

500 VIRGINIA ST E STE 200 25301-2177 CHARLESTON WV US, USA

Registration number: 1.1744.00154

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 70045.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 70,045 0 0 70,045
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 70,045 0 0 70,045
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 70,045 0 0 70,045
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 70,045 0 0 70,045
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 70,045 0 0 70,045
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agré&eacute") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 70,045 0 0 70,045
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 70,045 0 70,045

1


CITY OF PHILADELPHIA PUBLIC EMPLOYEES RETIREMENT SYSTEM

1500 JFK BLVD TWO PENN CENTER PLZ FL 16 19102-1727 PHILADELPHIA PA US, USA

Registration number: 1.1744.00155

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 2416.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 2,416 0 0 2,416
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 2,416 0 0 2,416
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 2,416 0 0 2,416
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 2,416 0 0 2,416
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 2,416 0 0 2,416
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agré&eacute") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 2,416 0 0 2,416
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 2,416 0 2,416

14 06


1199SEIU HEALTH CARE EMPLOYEES PENSION FUND

330 W 42ND ST 10036 NEW YORK NY US, USA

Registration number: 1.1744.00152

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 177109.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 177,109 0 0 177,109
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 177,109 0 0 177,109
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 177,109 0 0 177,109
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 177,109 0 0 177,109
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 177,109 0 0 177,109
7. Renewal of the appointment of the independent auditor of the Company ("récoute; viseur d'entreprises agrégées; éducateur") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 177,109 0 0 177,109
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 177,109 0 177,109

8


MW INV Strat Eureka Fund AC

C/O MARSHALL WACE IRELAND LIMITED 32 MOLESWORTH STREET D02Y512 DUBLIN IE, IRL

Registration number: 1.1744.00094

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 497.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 497 0 0 497
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 497 0 0 497
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 497 0 0 497
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 497 0 0 497
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 497 0 0 497
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agré&eacute") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 497 0 0 497
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 497 0 497

BlueHarbour MAP

C/O Maples Corporate Services Limited Ugland House, Grand Cayman KY1-1104 George Town KY, CYM

^{}[]

Registration number: 1.1744.00095

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 27112.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 27,112 0 0 27,112
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 27,112 0 0 27,112
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 27,112 0 0 27,112
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 27,112 0 0 27,112
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 27,112 0 0 27,112
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agré&eacute") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 27,112 0 0 27,112
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 27,112 0 27,112

ARROWSTREET INTL EQUITY ALPHA EXTN INTL TRADING

C/O ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ERIC BURNETT, 200 CLARENDON STREET, FLOOR 30 02116 BOSTON US, USA

Registration number: 1.1744.00096

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 41350.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 41,350 0 0 41,350
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 41,350 0 0 41,350
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 41,350 0 0 41,350
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 41,350 0 0 41,350
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 41,350 0 0 41,350
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 41,350 0 0 41,350
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 41,350 0 41,350

CPPIB MAP CAYMAN SPC SEGREGATED

C/O Maples Corporate Services Limited Ugland House, Grand Cayman KY1-1104 George Town KY, CYM

Registration number: 1.1744.00097

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 65691.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 65,691 0 0 65,691
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 65,691 0 0 65,691
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 65,691 0 0 65,691
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 65,691 0 0 65,691
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 65,691 0 0 65,691
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agré&eacute") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 65,691 0 0 65,691
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 65,691 0 65,691

MARSHALL WACE INV STRAT EUROPEAN TOPS
C/O MARSHALL WACE IRELAND LIMITED 32 MOLESWORTH STREET D02Y512 DUBLIN IE, IRL

Registration number: 1.1744.00098

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 2153.0
Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 2,153 0 0 2,153
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 2,153 0 0 2,153
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 2,153 0 0 2,153
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 2,153 0 0 2,153
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 2,153 0 0 2,153
7. Renewal of the appointment of the independent auditor of the Company ("récoute; viseur d'entreprises agrégées; éducateur") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 2,153 0 0 2,153
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 2,153 0 2,153

UNIVERSAL-INVESTMENT-GESELLSCHAFT MBH ON BEHALF OF STBV-NW-UNIVERSAL-FONDS

EUROPA-ALLEE 60486 FRANKFURT AM MAIN DE, DEU

img-1.jpeg

Registration number: 1.1744.00099
Shareclass: Ordinary Shares
Participation method: PRXY
Number of shares: 3209.0
Voting rights per share: 1.0
--- ---
Subject
--- ---
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026
7. Renewal of the appointment of the independent auditor of the Company ("récoute; viseur d'entreprises agrégée; éducateur") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025

ACADIAN GLOBAL SMALL-CAP EQUITY CIT

1 FREEDOM VALLEY DRIVE 19456 OAKS PENNSYLVANIA US, USA

Registration number: 1.1744.00100

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 17001.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 17,001 0 0 17,001
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 17,001 0 0 17,001
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 17,001 0 0 17,001
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 17,001 0 0 17,001
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 17,001 0 0 17,001
7. Renewal of the appointment of the independent auditor of the Company ("récoute; viseur d'entreprises agrégées; éducateur") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 17,001 0 0 17,001
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 17,001 0 17,001

UNIVERSAL-INVESTMENT-GESELLSCHAFT MBH W/ZEIT-UNIVERSAL-FONDS W/SEGMENT AKTIEN

REG:GRW12063MILE2010486 FRANKFURT AM MAIN GERMANY DE, DEU

Registration number: 1.1744.00101

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 2985.0
Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 2,985 0 0 2,985
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 2,985 0 0 2,985
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 2,985 0 0 2,985
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 2,985 0 0 2,985
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 2,985 0 0 2,985
7. Renewal of the appointment of the independent auditor of the Company ("récoute;viseur d'entreprises agrégée;écoute;") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 2,985 0 0 2,985
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 2,985 0 2,985

EBK-AKTIEN-UNIVERSAL-FONDS

EUROPA-ALLEE 92-96 60486 FRANKFURT AM MAIN GERMANY DE, DEU

Registration number: 1.1744.00102
Shareclass: Ordinary Shares
Participation method: PRXY
Number of shares: 17108.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 17,108 0 0 17,108
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 17,108 0 0 17,108
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 17,108 0 0 17,108
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 17,108 0 0 17,108
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 17,108 0 0 17,108
7. Renewal of the appointment of the independent auditor of the Company ("récoute; viseur d'entreprises agrégées; éducateur") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 17,108 0 0 17,108
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 17,108 0 17,108

NEW YORK STATE COMMON RETIREMENT FUND
110 STATE STREET 14TH FLOOR 12236-0001 ALBANY NEW YORK US, USA

Registration number: 1.1744.00103
Shareclass: Ordinary Shares
Participation method: PRXY
Number of shares: 38058.0
Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 38,058 0 0 38,058
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 38,058 0 0 38,058
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 38,058 0 0 38,058
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 38,058 0 0 38,058
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 38,058 0 0 38,058
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 38,058 0 0 38,058
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 38,058 0 38,058

SHELL TRUST (BERMUDA) LTD AS TRUSTEE OF THE SHELL OVERSEAS CONTRIBUTORY PENSION
CONTINENTAL BUILDING 3RD FLOOR 25 CHURCH STREET HM12 HAMILTON PEMBROKE BM, BMU

Registration number: 1.1744.00104

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 575.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 575 0 0 575
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 575 0 0 575
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 575 0 0 575
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 575 0 0 575
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 575 0 0 575
7. Renewal of the appointment of the independent auditor of the Company ("récueure d'entreprises agrégées") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 575 0 0 575
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 575 0 575

CBK Global SM.ART Equity Selection

Europa-Allee 60486 Frankfurt am Main DE, DEU

Registration number: 1.1744.00105

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 44276.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 44,276 0 0 44,276
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 44,276 0 0 44,276
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 44,276 0 0 44,276
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 44,276 0 0 44,276
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 44,276 0 0 44,276
7. Renewal of the appointment of the independent auditor of the Company ("récupéré, viseur d'entreprises agrégées, éducatives") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 44,276 0 0 44,276
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 44,276 0 44,276

CATHOLIC RESPONSIBLE INVESTMENTS INTERNATIONAL SMALL-CAP FUND

1 FREEDOM VALLEY DRIVE 19456 OAKS PENNSYLVANIA US, USA

Registration number: 1.1744.00106

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 28649.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 28,649 0 0 28,649
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 28,649 0 0 28,649
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 28,649 0 0 28,649
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 28,649 0 0 28,649
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 28,649 0 0 28,649
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agré&eacute") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 28,649 0 0 28,649
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 28,649 0 28,649

ENTERGY CORPORATION RETIREMENT PLANS MASTER TRUST

639 LOYOLA AVENUE ENT - 17F 70113-3176 NEW ORLEANS LOUISIANA US, USA

Registration number: 1.1744.00107

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 27067.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 27,067 0 0 27,067
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 27,067 0 0 27,067
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 27,067 0 0 27,067
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 27,067 0 0 27,067
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 27,067 0 0 27,067
7. Renewal of the appointment of the independent auditor of the Company ("récueure d'entreprises agrégées") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 27,067 0 0 27,067
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 27,067 0 27,067

LACM WORLD SMALL CAP EQUITY FUND LP

11150 SANTA MONICA BLVD STE 200 90025041850 LOS ANGELES CALIFORNIA US, USA

Registration number: 1.1744.00108

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 15294.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 15,294 0 0 15,294
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 15,294 0 0 15,294
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 15,294 0 0 15,294
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 15,294 0 0 15,294
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 15,294 0 0 15,294
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 15,294 0 0 15,294
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 15,294 0 15,294

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A. INVESTMENT FUNDS FOR EMPLOYEE BENEFIT
TRUST AND STREET 94105 SAN FRANCISCO CALIFORNIA US, USA

Registration number: 1.1744.00109

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 220916.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 220,916 0 0 220,916
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 220,916 0 0 220,916
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 220,916 0 0 220,916
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 0 220,916 0 220,916
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 220,916 0 0 220,916
7. Renewal of the appointment of the independent auditor of the Company ("récupter; viseur d'entreprises agrégées; éducateur") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 220,916 0 0 220,916
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 220,916 0 220,916

BLACKROCK MSCI EAFE SMALL CAP EQUITY INDEX FUND B (EAFESMLB

400 HOWARD STREET 94105 SAN FRANCISCO CALIFORNIA US, USA

Registration number: 1.1744.00110

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 4217.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 4,217 0 0 4,217
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 4,217 0 0 4,217
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 4,217 0 0 4,217
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 0 4,217 0 4,217
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 4,217 0 0 4,217
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 4,217 0 0 4,217
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 4,217 0 4,217

ALTRIA CLIENT SERVICES MASTER RETIREMENT TRUST

6601 WEST BROAD STREET 23230 RICHMOND VIRGINIA US, USA

Registration number: 1.1744.00111
Shareclass: Ordinary Shares
Participation method: PRXY
Number of shares: 104134.0
Voting rights per share: 1.0
--- ---
Subject Voted in favor
--- ---
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 104,134
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 104,134
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 104,134
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 104,134
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 104,134
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 104,134
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0

751 BROAD STREET 7102 NEWARK NEW JERSEY US, USA

PRUDENTIAL LEGACY INSURANCE COMPANY OF NEW JERSEY

Registration number: 1.1744.00112

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 29915.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 29,915 0 0 29,915
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 29,915 0 0 29,915
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 29,915 0 0 29,915
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 29,915 0 0 29,915
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 29,915 0 0 29,915
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 29,915 0 0 29,915
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 29,915 0 0 29,915

ROBERT BOSCH GMBH
ROBERT-BOSCH-PLATZ 1 D-70839 GERLINGEN-SCHILLERHOEHE DE, DEU

Registration number: 1.1744.00113
Shareclass: Ordinary Shares
Participation method: PRXY
Number of shares: 58052.0
Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 58,052 0 0 58,052
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 58,052 0 0 58,052
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 58,052 0 0 58,052
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 58,052 0 0 58,052
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 58,052 0 0 58,052
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 58,052 0 0 58,052
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 58,052 0 58,052

UI-FONDS BAV RBI AKTIEN
EUROPA-ALLEE 92-96 60486 FRANKFURT AM MAIN DE, DEU

Registration number: 1.1744.00114
Shareclass: Ordinary Shares
Participation method: PRXY
Number of shares: 6991.0
Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 6,991 0 0 6,991
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 6,991 0 0 6,991
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 6,991 0 0 6,991
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 6,991 0 0 6,991
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 6,991 0 0 6,991
7. Renewal of the appointment of the independent auditor of the Company ("récoute; viseur d'entreprises agrégée; éducateur") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 6,991 0 0 6,991
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 6,991 0 6,991

ACADIAN ALL COUNTRY WORLD EX-US EX-CHINA EQUITY CIT

1 FREEDOM VALLEY DRIVE 19456 OAKS PENNSYLVANIA US, USA

Registration number: 1.1744.00115

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 30475.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 30,475 0 0 30,475
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 30,475 0 0 30,475
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 30,475 0 0 30,475
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 30,475 0 0 30,475
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 30,475 0 0 30,475
7. Renewal of the appointment of the independent auditor of the Company ("récueure d'entreprises agrégées") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 30,475 0 0 30,475
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 30,475 0 30,475

T

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A. INVESTMENT FUNDS FOR EMPLOYEE BENEFIT

TREASURER'S TREATY
TREASURER'S TREATY
TREASURER'S TREATY

TRUSTS
TREASURER'S TREATY

TREASURER'S TREATY
**TREASURER'S TREATY

TREASURER'S TREATY
**TREASURER'S TREATY

Registration number: 1.1744.00116
Shareclass: Ordinary Shares
Participation method: PRXY
Number of shares: 3605.0
Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 3,605 0 0 3,605
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 3,605 0 0 3,605
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 3,605 0 0 3,605
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 0 3,605 0 3,605
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 3,605 0 0 3,605
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 3,605 0 0 3,605
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 3,605 0 3,605

THRIFT SAVINGS PLAN
77K STREET NE SUITE 1000 20002 WASHINGTON, D.C. DIST. OF COLUMBIA US, USA

Registration number: 1.1744.00117

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 156586.0
Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 156,586 0 0 156,586
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 156,586 0 0 156,586
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 156,586 0 0 156,586
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 0 156,586 0 156,586
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 156,586 0 0 156,586
7. Renewal of the appointment of the independent auditor of the Company ("récoute; viseur d'entreprises agrégées; éducateur") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 156,586 0 0 156,586
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 156,586 0 156,586

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A. INVESTMENT FUNDS FOR EMPLOYEE BENEFIT
TRUSTS AND STREET 94105 SAN FRANCISCO CALIFORNIA US, USA

Registration number: 1.1744.00118

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 5863.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 5,863 0 0 5,863
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 5,863 0 0 5,863
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 5,863 0 0 5,863
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 0 5,863 0 5,863
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 5,863 0 0 5,863
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 5,863 0 0 5,863
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 5,863 0 5,863

BERENBERG EUROPEAN MICRO CAP
RUE DE FLAXWEILER 6776 GREVENMACHER LU, LUX

Registration number: 1.1744.00119
Shareclass: Ordinary Shares
Participation method: PRXY
Number of shares: 179047.0
Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 179,047 0 0 179,047
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 179,047 0 0 179,047
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 179,047 0 0 179,047
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 179,047 0 0 179,047
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 179,047 0 0 179,047
7. Renewal of the appointment of the independent auditor of the Company ("récueure d'entreprises agrégées") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 179,047 0 0 179,047
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 179,047 0 179,047

SONICSHARES GLOBAL SHIPPING ETF

234 W FLORIDA ST STE 203 MILWAUKEE, WI 53204 53204 MILWAUKEE WISCONSIN US, USA

Registration number: 1.1744.00120

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 76425.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 76,425 0 0 76,425
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 76,425 0 0 76,425
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 76,425 0 0 76,425
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 76,425 0 0 76,425
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 76,425 0 0 76,425
7. Renewal of the appointment of the independent auditor of the Company ("récueure d'entreprises agrégées") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 76,425 0 0 76,425
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 76,425 0 0 76,425

T

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A. INVESTMENT FUNDS FOR EMPLOYEE BENEFIT

TIR HOTELS
AND STREET 94105 SAN FRANCISCO CALIFORNIA US, USA

Registration number: 1.1744.00121

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 56543.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 56,543 0 0 56,543
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 56,543 0 0 56,543
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 56,543 0 0 56,543
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 0 56,543 0 56,543
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 56,543 0 0 56,543
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agré&eacute") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 56,543 0 0 56,543
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 56,543 0 56,543

SHELL TRUST (BERMUDA) LIMITED AS TRUSTEE OF THE SHELL INTERNATIONAL PENSION FUND

CONTINENTAL BUILDING 3RD FLOOR 25 CHURCH STREET HM12 HAMILTON PEMBROKE BM, BMU

Registration number: 1.1744.00122

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 338.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 338 0 0 338
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 338 0 0 338
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 338 0 0 338
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 338 0 0 338
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 338 0 0 338
7. Renewal of the appointment of the independent auditor of the Company ("récoute; viseur d'entreprises agrégée; écute; " for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 338 0 0 338
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 338 0 338

WILSHIRE INTL EQUITY FUND (VOYA)

ATTN-GAURAV CHOPRA C/O WILSHIRE ASSOCIATES, INC. 90401 SANTA MONICA CALIFORNIA US, USA

Registration number: 1.1744.00123

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 11746.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 11,746 0 0 11,746
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 11,746 0 0 11,746
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 11,746 0 0 11,746
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 11,746 0 0 11,746
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 11,746 0 0 11,746
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 11,746 0 0 11,746
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 11,746 0 11,746

VANGUARD INVESTMENT SERIES PUBLIC LIMITED COMPANY
70 SIR JOHN ROGERSONS QUAY D02R296 DUBLIN 2 IE, IRL

Registration number: 1.1744.00124
Shareclass: Ordinary Shares
Participation method: PRXY
Number of shares: 27080.0
Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 27,080 0 0 27,080
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 27,080 0 0 27,080
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 27,080 0 0 27,080
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 27,080 0 0 27,080
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 27,080 0 0 27,080
7. Renewal of the appointment of the independent auditor of the Company ("récoute; viseur d'entreprises agrégées; " for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 27,080 0 0 27,080
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 27,080 0 27,080

CHURCH COMMISSIONERS FOR ENGLAND

CHURCH HOUSE GREAT SMITH STREET SW1P3AZ LONDON GB, GBR

Registration number: 1.1744.00125

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 533744.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 533,744 0 0 533,744
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 533,744 0 0 533,744
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 533,744 0 0 533,744
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 533,744 0 0 533,744
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 533,744 0 0 533,744
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 533,744 0 0 533,744
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 533,744 0 533,744

ACADIAN INTERNATIONAL SMALL-CAP EQUITY CIT

1 FREEDOM VALLEY DR 19456 OAKS PENNSYLVANIA US, USA

H

Registration number: 1.1744.00126

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 41398.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 41,398 0 0 41,398
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 41,398 0 0 41,398
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 41,398 0 0 41,398
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 41,398 0 0 41,398
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 41,398 0 0 41,398
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 41,398 0 0 41,398
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 41,398 0 41,398

SEI INSTITUTIONAL INVESTMENTS TRUST WORLD EQUITY EX-US FUND

ONE FREEDOM VALLEY DRIVE 19456 OAKS PENNSYLVANIA US, USA

Registration number: 1.1744.00127

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 196193.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 196,193 0 0 196,193
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 196,193 0 0 196,193
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 196,193 0 0 196,193
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 196,193 0 0 196,193
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 196,193 0 0 196,193
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 196,193 0 0 196,193
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 196,193 0 196,193

ACADIAN ALL COUNTRY WORLD EX US SMALL-CAP EQUITY CIT

1 FREEDOM VALLEY DRIVE 19456 OAKS PENNSYLVANIA US, USA

img-0.jpeg

Registration number: 1.1744.00128
Shareclass: Ordinary Shares
Participation method: PRXY
Number of shares: 34975.0
Voting rights per share: 1.0
--- ---
Subject
--- ---
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025

CC AND L Q MARKET NEUTRAL FUND II

2200-1111 GEORGIA STREET, BC, V6E 4M3 M5H2R2 VANCOUVER CA, CAN

^{}[]

Registration number: 1.1744.00129

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 8.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 8 0 0 8
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 8 0 0 8
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 8 0 0 8
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 8 0 0 8
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 8 0 0 8
7. Renewal of the appointment of the independent auditor of the Company ("récoute;viseur d'entreprises agrégée;écoute;") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 8 0 0 8
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 8 0 8

CC AND L Q GLOBAL EQUITY MARKET NEUTRAL MASTER FUND LTD

44 KING STREET WEST M5H1H1 TORONTO CA, CAN

Registration number: 1.1744.00130

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 10.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 10 0 0 10
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 10 0 0 10
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 10 0 0 10
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 10 0 0 10
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 10 0 0 10
7. Renewal of the appointment of the independent auditor of the Company ("récueure d'entreprises agrégées") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 10 0 0 10
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 10 0 10

CC AND L Q MARKET NEUTRAL FUND

1111 WEST GEORGIA STREET V6E4M3 VANCOUVER CA, CAN

Registration number: 1.1744.00131

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 14.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 14 0 0 14
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 14 0 0 14
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 14 0 0 14
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 14 0 0 14
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 14 0 0 14
7. Renewal of the appointment of the independent auditor of the Company ("récueure d'entreprises agrégées") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 14 0 0 14
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 14 0 14

FIDELITY INVESTMENT FUNDS - FIDELITY INDEX WORLD ESG SCREENED FUND

BEECHGATE, MILLFIELD LANE LOWER KINGSWOOD KT206RP TADWORTH SURREY GB, GBR

Registration number: 1.1744.00132

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 142.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 142 0 0 142
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 142 0 0 142
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 142 0 0 142
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 142 0 0 142
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 142 0 0 142
7. Renewal of the appointment of the independent auditor of the Company ("récoute;viseur d'entreprises agrégée;écoute;" for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 142 0 0 142
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 142 0 142

ONEPATH GLOBAL SHARES - SMALL CAP (UNHEDGED) INDEX POOL

800 BOURKE STREET 3008 DOCKLANDS VICTORIA AU, AUS

img-1.jpeg

Registration number: 1.1744.00133

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 618.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 618 0 0 618
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 618 0 0 618
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 618 0 0 618
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 618 0 0 618
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 618 0 0 618
7. Renewal of the appointment of the independent auditor of the Company ("récueure d'entreprises agrégées") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 618 0 0 618
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 618 0 618

MW INV STRAT EUREKA FUND AC

C/O MARSHALL WACE IRELAND LIMITED 32 MOLESWORTH STREET D02Y512 Dublin 2 DUBLIN IE, IRL

^{}[]

Registration number: 1.1744.00134

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 497.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 497 0 0 497
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 497 0 0 497
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 497 0 0 497
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 497 0 0 497
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 497 0 0 497
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agré&eacute") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 497 0 0 497
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 497 0 497

CITADEL SECURITES LLC (ILG)

C/O THE CORPORATION TRUST COMPANY CORPORATION TRUST CENTER 19801 1209 ORANGE ST Wilmington DELAWARE US, USA

Registration number: 1.1744.00135

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 101.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 101 0 0 101
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 101 0 0 101
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 101 0 0 101
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 101 0 0 101
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 101 0 0 101
7. Renewal of the appointment of the independent auditor of the Company ("récueure d'entreprises agrégées") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 101 0 0 101
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 101 0 0 101

MARSHALL WACE INV STRAT EUROPEAN TOPS
C/O MARSHALL WACE IRELAND LIMITED 32 MOLESWORTH STREET D02Y512 Dublin 2 DUBLIN IE, IRL

Registration number: 1.1744.00136

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 2153.0
Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 2,153 0 0 2,153
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 2,153 0 0 2,153
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 2,153 0 0 2,153
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 2,153 0 0 2,153
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 2,153 0 0 2,153
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 2,153 0 0 2,153
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 2,153 0 2,153

CPPIB MAP CAYMAN SPC SEGREGATED (GCM)

C/O MAPLES CORPORATE SERVICES LIMITED, UGLAND HOUSE KY1-1104 George Town GRAND CAYMAN KY, CYM

Registration number: 1.1744.00137

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 65691.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 65,691 0 0 65,691
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 65,691 0 0 65,691
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 65,691 0 0 65,691
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 65,691 0 0 65,691
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 65,691 0 0 65,691
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 65,691 0 0 65,691
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 65,691 0 65,691

ARROWSTREET INTL EQUITY ALPHA EXTN INTL TRADING
200 CLARENDON STREET 02116 Boston MA US, USA

Registration number: 1.1744.00138
Shareclass: Ordinary Shares
Participation method: PRXY
Number of shares: 41350.0
Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 41,350 0 0 41,350
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 41,350 0 0 41,350
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 41,350 0 0 41,350
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 41,350 0 0 41,350
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 41,350 0 0 41,350
7. Renewal of the appointment of the independent auditor of the Company ("réviseur d'entreprises agréé") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 41,350 0 0 41,350
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 41,350 0 41,350

Amundi Etf ICAV - Amundi S and P 500 Equal Weight Esg Leaders Ucits Etf

One Georges Quay Plaza, Co Dublin D02YY95 Dublin IE, IRL

^{}[]

Registration number: 1.1744.00139

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 11868.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 11,868 0 0 11,868
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 11,868 0 0 11,868
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 11,868 0 0 11,868
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 11,868 0 0 11,868
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 11,868 0 0 11,868
7. Renewal of the appointment of the independent auditor of the Company ("récueur d'entreprises agrégées") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 11,868 0 0 11,868
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 11,868 0 11,868

RAM (LUX) SYSTEMATIC FUNDS
BOULEVARD ROYAL 2449 LUXEMBOURG LU, LUX

Registration number: 1.1744.00140
Shareclass: Ordinary Shares
Participation method: PRXY
Number of shares: 91205.0
Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 91,205 0 0 91,205
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 91,205 0 0 91,205
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 91,205 0 0 91,205
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 91,205 0 0 91,205
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 91,205 0 0 91,205
7. Renewal of the appointment of the independent auditor of the Company ("récup租借" / "viseur d'entreprises agrégées") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 91,205 0 0 91,205
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 91,205 0 0 91,205

DES VAL INTL.PEEQ CSH NON FLIP

DES VALENCE INTL.- PEEQ - CASH NON FLIP 9TH FLOOR NEW YORK NY 10036-2750 ROAD TOWN US, USA

1

Registration number: 1.1744.00141

Shareclass: Ordinary Shares

Participation method: PRXY

Number of shares: 26317.0

Voting rights per share: 1.0

Subject Voted in favor Voted against Abstained Total
2. Consideration and approval of the Company's statutory annual accounts for the financial year ended on 31 December 2025 26,317 0 0 26,317
3. Consideration and approval of the Company's consolidated annual accounts for the financial year ended on 31 December 2025 26,317 0 0 26,317
4. Approval of the allocation of results of the financial year ended on 31 December 2025 and payment of dividends in relation to the financial year ended on 31 December 2025 26,317 0 0 26,317
5. Discharge to the members of the Board of Directors in respect of the performance of their duties during the financial year ended on 31 December 2025 26,317 0 0 26,317
6. Approval of fees payable to the members of the Board of Directors for the financial year 2026 26,317 0 0 26,317
7. Renewal of the appointment of the independent auditor of the Company ("récoute;viseur d'entreprises agrégée;échec") for a period ending at the Company's annual general meeting of shareholders called to approve the 2028 consolidated and statutory annual accounts of the Company 26,317 0 0 26,317
8. Consideration and advisory vote on the general remuneration policy for the financial year 2026 and on the remuneration report for the financial year ended on 31 December 2025 0 26,317 0 26,317